| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2100042592 |
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Cervical Cancer |
Diagnostic Accuracy Test |
Post-market |
2024-06-09 | 556 | Patient list |
| 暂无 |
Affiliate Hospital of Guilin Medical University |
cervical cancer |
Therapy Study |
Post-market |
2023-10-26 | 371 | Patient list |
| 无 |
|
cervical cancer |
Therapy Study |
Premarket |
2023-10-09 | 349 | Patient list |
| ChiCTR2100042033 |
DC-CTL cell therapy technology for advanced cervical cancer People's Hospital of Xinjiang Uygur Autonomous Region |
Cervical cancer |
Therapy Study |
Premarket |
2021-01-05 | 1301 | Patient list |
| ChiCTR2000034596 |
Development of early warning index for cervical cancer based on vaginal microecological The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University |
cervical cancer |
Therapy Study |
Premarket |
2020-07-12 | 1213 | Patient list |
| ChiCTR2000030957 |
Application of modified laparoscopic radical hysterectomy in stage IA2-IB1 cervical cancer Sun Yat-Sen memorial hospital of Sun Yat-Sen university |
Cervical cancer |
Diagnostic Accuracy Test |
Post-market |
2020-04-02 | 1215 | Patient list |
| ChiCTR1900024143 |
Shandong Academy of Medical Sciences |
Cervical Cancer |
Therapy Study |
Post-market |
2019-06-27 | 1458 | Patient list |
| ChiCTR1900023822 |
The First Affiliated Hospital of Guangzhou University of Chinese Medicine |
Cervical Cancer |
Therapy Study |
Post-market |
2019-06-13 | 1318 | Patient list |
| ChiCTR1800020030 |
|
Cervical cancer |
Therapy Study |
Post-market |
2019-06-05 | 1350 | Patient list |
| ChiCTR1900023144 |
Phase II study of concurrent chemoradiotherapy with recombinant human endostatin for cervical cancer Peking University Cancer Hospital |
cervical cancer |
Therapy Study |
Post-market |
2019-05-12 | 1138 | Patient list |